Quick Answer
Moderna, Inc. reported Shares Outstanding of 394.00 million shares for fiscal year 2025.
Moderna, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 394.00M | +2.1% |
| 2024 | 386.00M | +1.0% |
| 2023 | 382.00M | -0.8% |
| 2022 | 385.00M | -4.5% |
| 2021 | 403.00M | +1.0% |
| 2020 | 399.00M | +18.6% |
| 2019 | 336.54M | +2.4% |
| 2018 | 328.80M | +404.2% |
| 2017 | 65.21M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 391.00M | +1.6% | +0.5% |
| June 30, 2025 | 389.00M | +1.3% | +0.5% |
| March 31, 2025 | 387.00M | +1.0% | +0.3% |
| December 31, 2024 | 386.00M | +1.0% | +0.3% |
| September 30, 2024 | 385.00M | +1.0% | +0.3% |
| June 30, 2024 | 384.00M | +0.8% | +0.3% |
| March 31, 2024 | 383.00M | -0.3% | +0.3% |
| December 31, 2023 | 382.00M | -0.8% | +0.3% |
- Moderna, Inc. showed an increase of +2.1% in Shares Outstanding compared to the prior fiscal year.
- Over the 2017–2025 period, Moderna, Inc.’s shares outstanding has grown by 504.2% (from 65.21 million shares to 394.00 million shares).
- The most recent figure is from Moderna, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: